Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
In his new role, Karthik will lead human capital strategy and HR operations across these regions
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
A major push to sharpen the future of cancer treatment is underway
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
